The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Cohen & Steers Inc (NYSE: CNS) closed at $73.86 down -0.22% from its previous closing price of $74.02. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 0.47 million shares were traded. CNS stock price reached its highest trading level at $74.501 during the session, while it also had its lowest trading level at $72.93.
Ratios:
For a deeper understanding of Cohen & Steers Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.19. For the most recent quarter (mrq), Quick Ratio is recorded 4.80 and its Current Ratio is at 4.80. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.27.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on June 30, 2025, initiated with a Underperform rating and assigned the stock a target price of $67.
On October 17, 2024, UBS Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $63 to $102.
On January 05, 2024, UBS started tracking the stock assigning a Sell rating and target price of $68.UBS initiated its Sell rating on January 05, 2024, with a $68 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 09 ’25 when Cheigh Jon sold 25,500 shares for $80.01 per share. The transaction valued at 2,040,255 led to the insider holds 142,431 shares of the business.
Cheigh Jon bought 25,500 shares of CNS for $2,040,216 on May 09 ’25. On Dec 02 ’24, another insider, Charles Daniel P, who serves as the Executive Vice President of the company, sold 6,868 shares for $103.74 each. As a result, the insider received 712,463 and left with 46,040 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNS now has a Market Capitalization of 3766616320 and an Enterprise Value of 3691878400. As of this moment, Cohen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.47, and their Forward P/E ratio for the next fiscal year is 21.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.92 while its Price-to-Book (P/B) ratio in mrq is 7.13. Its current Enterprise Value per Revenue stands at 6.792 whereas that against EBITDA is 19.03.
Stock Price History:
The Beta on a monthly basis for CNS is 1.40, which has changed by -0.15646416 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, CNS has reached a high of $110.67, while it has fallen to a 52-week low of $68.99. The 50-Day Moving Average of the stock is -1.93%, while the 200-Day Moving Average is calculated to be -10.95%.
Shares Statistics:
For the past three months, CNS has traded an average of 217.96K shares per day and 285440 over the past ten days. A total of 50.99M shares are outstanding, with a floating share count of 27.47M. Insiders hold about 46.14% of the company’s shares, while institutions hold 58.73% stake in the company. Shares short for CNS as of 1755216000 were 1933351 with a Short Ratio of 8.87, compared to 1752537600 on 1964749. Therefore, it implies a Short% of Shares Outstanding of 1933351 and a Short% of Float of 6.9299996.
Dividends & Splits
According to the company, the forward annual dividend rate for CNS is 2.45, from 2.42 in the trailing year. Against a Trailing Annual Dividend Yield of 0.03269387The stock’s 5-year Average Dividend Yield is 2.85.
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. The consensus estimate for the next quarter is $0.81, with high estimates of $0.82 and low estimates of $0.79.
Analysts are recommending an EPS of between $3.09 and $3.04 for the fiscal current year, implying an average EPS of $3.07. EPS for the following year is $3.43, with 3.0 analysts recommending between $3.49 and $3.33.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $138.84M this quarter.It ranges from a high estimate of $139.13M to a low estimate of $138.55M. As of the current estimate, Cohen & Steers Inc’s year-ago sales were $133.2MFor the next quarter, 2 analysts are estimating revenue of $144.02M. There is a high estimate of $146.49M for the next quarter, whereas the lowest estimate is $141.56M.
A total of 2 analysts have provided revenue estimates for CNS’s current fiscal year. The highest revenue estimate was $555.62M, while the lowest revenue estimate was $549.81M, resulting in an average revenue estimate of $552.72M. In the same quarter a year ago, actual revenue was $517.42MBased on 2 analysts’ estimates, the company’s revenue will be $620.44M in the next fiscal year. The high estimate is $646.25M and the low estimate is $594.63M.
